Article
Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
2021-05-11
Abstract excerpt
Molnupiravir is an orally available antiviral drug candidate that is in phase III trials for the treatment of COVID-19 patients 1,2 . Molnupiravir increases the frequency of viral RNA mutations 3,4 and impairs SARS-CoV-2 replication in animal models 4-6 and in patients 2 . Here we establish the molecular mechanisms that underlie molnupiravir-induced RNA mutagenesis by the RNA-dependent RNA polymerase (RdRp) of...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2227dd4e-8ec5-5c43-b068-ebb74c1c7092
- DOI
- 10.1101/2021.05.11.443555
